Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
Información
- DOI:
- https://doi.org/10.1002/14651858.CD012857Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 15 noviembre 2017see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Protocol
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Problemas de desarrollo, psicosociales y de aprendizaje
- Copyright:
-
- Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
KB drafted the protocol and has overall responsibility for the review.
All authors contributed to writing the protocol.
Sources of support
Internal sources
-
Nordic Cochrane Centre, Denmark.
Supported all review authors: KB, PD, PG and KJ.
External sources
-
None, Other.
Declarations of interest
Kim Boesen is a researcher with the Nordic Cochrane Centre.
Pia Brandt Danborg is a researcher with the Nordic Cochrane Centre.
Peter C Gøtzsche is the Director of the Nordic Cochrane Centre.
Karsten Juhl Jørgensen is the Deputy Director of the Nordic Cochrane Centre.
Acknowledgements
We thank Jørn Wetterslev for helping us understand Trial Sequential Analysis.
This protocol was produced within the Cochrane Developmental, Psychosocial and Learning Problems Review Group.
Version history
| Published | Title | Stage | Authors | Version |
| 2022 Feb 24 | Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults | Review | Kim Boesen, Asger Sand Paludan-Müller, Peter C Gøtzsche, Karsten Juhl Jørgensen | |
| 2017 Nov 15 | Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults | Protocol | Kim Boesen, Pia Brandt Danborg, Peter C Gøtzsche, Karsten Juhl Jørgensen | |
